Jupiter Asset Management Ltd. Has $12,968,000 Position in CVS Health Corporation (CVS)

Jupiter Asset Management Ltd. continued to hold its stake in CVS Health Corporation (NYSE:CVS) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 165,202 shares of the pharmacy operator’s stock at the end of the first quarter. Jupiter Asset Management Ltd.’s holdings in CVS Health Corporation were worth $12,968,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in CVS. Alpha Windward LLC boosted its stake in CVS Health Corporation by 1.5% in the first quarter. Alpha Windward LLC now owns 3,302 shares of the pharmacy operator’s stock worth $259,000 after buying an additional 49 shares during the last quarter. Proffitt & Goodson Inc. boosted its stake in shares of CVS Health Corporation by 0.4% in the first quarter. Proffitt & Goodson Inc. now owns 15,782 shares of the pharmacy operator’s stock worth $1,239,000 after buying an additional 65 shares in the last quarter. BLB&B Advisors LLC boosted its stake in shares of CVS Health Corporation by 0.4% in the first quarter. BLB&B Advisors LLC now owns 16,355 shares of the pharmacy operator’s stock worth $1,284,000 after buying an additional 72 shares in the last quarter. Oxbow Advisors LLC boosted its stake in shares of CVS Health Corporation by 0.8% in the first quarter. Oxbow Advisors LLC now owns 12,090 shares of the pharmacy operator’s stock worth $949,000 after buying an additional 90 shares in the last quarter. Finally, Dumont & Blake Investment Advisors LLC boosted its stake in shares of CVS Health Corporation by 0.6% in the first quarter. Dumont & Blake Investment Advisors LLC now owns 16,122 shares of the pharmacy operator’s stock worth $1,266,000 after buying an additional 90 shares in the last quarter. 82.31% of the stock is owned by hedge funds and other institutional investors.

CVS Health Corporation (NYSE:CVS) opened at 77.66 on Friday. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $98.44. The company has a market capitalization of $78.95 billion, a price-to-earnings ratio of 15.47 and a beta of 0.91. The company’s 50-day moving average price is $78.68 and its 200 day moving average price is $78.94.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.02. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period last year, the firm posted $1.32 earnings per share. On average, analysts predict that CVS Health Corporation will post $5.88 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 3rd. Investors of record on Monday, July 24th were paid a $0.50 dividend. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.00 dividend on an annualized basis and a yield of 2.58%. CVS Health Corporation’s dividend payout ratio (DPR) is 39.92%.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by BNB Daily and is the property of of BNB Daily. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The original version of this piece of content can be accessed at https://www.baseball-news-blog.com/2017/08/19/jupiter-asset-management-ltd-continues-to-hold-stake-in-cvs-health-corporation-cvs-updated.html.

A number of brokerages have weighed in on CVS. Vetr cut CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 price target for the company. in a research report on Monday, June 12th. Guggenheim reaffirmed a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Needham & Company LLC began coverage on CVS Health Corporation in a research report on Tuesday, June 27th. They issued a “hold” rating for the company. Citigroup Inc. reduced their price target on CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Thursday. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $82.00 price target on shares of CVS Health Corporation in a research report on Friday, July 14th. Nine equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. CVS Health Corporation currently has an average rating of “Buy” and an average target price of $91.24.

In related news, Director Richard J. Swift sold 2,500 shares of CVS Health Corporation stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total value of $199,050.00. Following the transaction, the director now directly owns 3,258 shares of the company’s stock, valued at $259,401.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO David M. Denton sold 230,510 shares of CVS Health Corporation stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the transaction, the chief financial officer now directly owns 176,983 shares in the company, valued at $14,158,640. The disclosure for this sale can be found here. Insiders sold 273,675 shares of company stock worth $21,831,647 over the last three months. 0.61% of the stock is currently owned by insiders.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply